Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $6.35 Million - $7.36 Million
57,100 Added 74.93%
133,300 $15.1 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $1.52 Million - $1.64 Million
12,300 Added 19.25%
76,200 $9.43 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $158,536 - $184,729
-1,400 Reduced 2.14%
63,900 $8.43 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $6.26 Million - $6.81 Million
62,500 Added 2232.14%
65,300 $7.12 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $20,590 - $22,866
-200 Reduced 6.67%
2,800 $288,000
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $314,969 - $343,302
2,900 Added 2900.0%
3,000 $346,000
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $10,294 - $11,486
100 New
100 $10,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.